Exchange Plan Drug Trend: Diabetes, HIV, HCV Are Tops In Spending
This article was originally published in The Pink Sheet Daily
Executive Summary
Express Scripts says total specialty drug spend for exchange enrollees rose 24% in one year, largely due to HIV and hepatitis C drugs. More recent enrollees are younger, spend less.